The Fred Hutchinson/University of Washington Cancer Consortium is a new entity formed from the Fred Hutchinson Cancer Research Center, a comprehensive cancer center and 30-year CCSG recipient, and its strong collaborators, the University of Washington and Children's Hospital. The consortium brings roger nearly 300 faculty with research interests in basic, clinical-and public health sciences related to cancer, with a total NCI funding of $112 million. The goal of the Consortium is the elimination of cancer through more effective prevention, diagnostics, and treatment, deriving from fundamental insights into the biology of the disease. New opportunities to reduce the suffering and mortality from cancer are to be found in the interdisciplinary collaboration of scientists in basic, clinical and public health sciences exploiting new information and technology. The Consortium faculty are organized into 16 productive research programs with the emphasis in the Public Health (Biostatistics, Epidemiology, Prevention), Clinical (Transplantation Biology, Clinical Transplantation, Human Immunogenetics, Immunology, Infectious Disease), Fundamental sciences (Basic, Human Biology), and programs that impact all three disciplines (Breast, Prostate, Gynecologic, Genetics, Imaging, and Genetic Instability). During the next grant period the Consortium will seek to develop additional strength in three areas: (1) To increase scientific collaboration and interactions afforded by the new consortium arrangement. (2) To build on existing strengths in immunologic and molecular approaches to solid tumor diagnosis, treatment and prevention. Prior experience in the development of successful new therapeutic approaches for leukemia and lymphoma and the new partnership in cancer clinical care which has been formed between the members of the Consortium, the Seattle Cancer Care Alliance will also contribute to achieving this goal. (3) The Consortium will be a leader in the application of molecular approaches to population sciences. New laboratories will be dedicated to this objective in the new Public Health Sciences Building currently under construction.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA015704-30S1
Application #
6767495
Study Section
Subcommittee G - Education (NCI)
Program Officer
Rosenfeld, Bobby
Project Start
1977-01-01
Project End
2007-12-31
Budget Start
2003-05-01
Budget End
2003-12-31
Support Year
30
Fiscal Year
2003
Total Cost
$103,800
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Ranola, John Michael O; Pearlman, Rachel; Hampel, Heather et al. (2018) Modified capture-recapture estimates of the number of families with Lynch syndrome in Central Ohio. Fam Cancer :
Yeung, Cecilia C S; McElhone, Scott; Chen, Xue Yan et al. (2018) Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome. Mod Pathol 31:569-580
Leger, Kasey J; Baker, K Scott; Cushing-Haugen, Kara L et al. (2018) Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation. Cancer 124:1507-1515
Boucoiran, Isabelle; Mayer, Bryan T; Krantz, Elizabeth M et al. (2018) Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants. Pediatr Infect Dis J 37:627-631
Dai, James Y; Liang, C Jason; LeBlanc, Michael et al. (2018) Case-only approach to identifying markers predicting treatment effects on the relative risk scale. Biometrics 74:753-763
Huang, Yijian; Wang, Ching-Yun (2018) Cox regression with dependent error in covariates. Biometrics 74:118-126
Hempstead, Bridgette; Green, Cynthia; Briant, Katherine J et al. (2018) Community Empowerment Partners (CEPs): A Breast Health Education Program for African-American Women. J Community Health 43:833-841
OhAinle, Molly; Helms, Louisa; Vermeire, Jolien et al. (2018) A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV. Elife 7:
Syrjala, Karen L; Yi, Jean C; Artherholt, Samantha B et al. (2018) An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation. J Cancer Surviv 12:560-570
Liu, Yang; He, Qianchan; Sun, Wei (2018) Association analysis using somatic mutations. PLoS Genet 14:e1007746

Showing the most recent 10 out of 1267 publications